Author

T. Bhadra

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access 2026

Resmetirom: A New FDA-approved Drug as a Targeted Therapeutic Strategy in Metabolic Dysfunction Associated Steatohepatitis: Translational Evidence from Current Clinical Trials.

Metabolic dysfunction-associated steatohepatitis (MASH) represents a significant global health burden, affecting 3-5% of the population and projected to become a leading cause of liver transplantation by 2030. This review examines Resmetirom, the first FDA-approved drug for non-cirrhotic MASH with moderate to severe he...

Ghulam Hassam U. Din Tarrar, Syed Shafaat Hussain, M. Sarfraz et al. · Prague Medical Report · 0 citations

Review Open access Sep 2026

Diagnostic Accuracy of Machine Learning-Enhanced Methods for Pulmonary Hypertension: A Systematic Review and Meta-Analysis

Background/Objectives: Right heart catheterization (RHC) is the diagnostic gold standard for pulmonary hypertension (PH), defined as mean pulmonary arterial pressure (mPAP) greater than 20 mmHg at rest. It is invasive and carries procedural risk. Machine learning (ML) and deep learning (DL) applied to non-invasive moda...

Faizan Ahmed, A. Zulfiqar, T. Bhadra et al. · Diagnostics · 0 citations